J&J Shot Performs Poorly Against Delta Variant J&J Shot Performs Poorly Against Delta Variant The laboratory study, released on the preprint server bioRxiv, hasn t been published in a peer-reviewed journal and focuses on one key portion of the immune response, called neutralizing antibodies.
The study examined only one aspect of protection, J&J said in an email (File)
Johnson & Johnson s single-dose Covid vaccine produced relatively low levels of antibodies against the delta variant in a study, raising questions about how well the shot will hold up against the strain that accounts for the vast majority of U.S. cases.
(July 21): Johnson & Johnson’s single-dose Covid vaccine produced relatively low levels of antibodies against the delta variant in a study, raising questions about how well the shot will hold up against the strain that accounts for the vast majority of U.S. cases.
The laboratory study, released on the preprint server bioRxiv, hasn’t been published in a peer-reviewed journal and focuses on one key portion of the immune response, called neutralizing antibodies. New York University scientists found that J&J’s vaccine produced roughly five-fold lower levels of the protective antibodies against the delta variant compared to the levels raised against an early coronavirus strain.
J&J vaccine produced relatively low levels of antibodies against Delta variant, says study biznews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biznews.com Daily Mail and Mail on Sunday newspapers.
Jurors on Long Island are set to determine whether a group of opioid makers and drug distributors created a public health crisis and should pay for it, in a bellwether trial for lawsuits filed by communities across the U.S.
Endo International, Teva Pharmaceutical Industries and McKesson are among the companies that New York Attorney General Letitia James and Nassau and Suffolk counties say made billions of dollars selling the highly addictive pills while illegally marketing them or turning a blind eye to suspiciously large orders.
Opening arguments in the Central Islip trial are scheduled to start Tuesday.
The stakes are high for the industry.
Drug Industry Faces First High-Stakes Opioid Jury Trial insurancejournal.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insurancejournal.com Daily Mail and Mail on Sunday newspapers.